Sr. Regional Sales Manager/ Regional Sales Manager
About the Company
Goodman Pharmaceuticals Ltd. (a sister concern of MIMPEX Group) is one of the leading manufacturers of pharmaceutical finished products of Bangladesh having WHO cGMP compliant manufacturing facility. It’s now manufacturing more than 140 products including life saving antibiotics of many therapeutic classes in different dosage forms and presentations such as tablet, capsule, syrup, suspension, powder for suspension, solution and pediatric drops. It is committed to ensuring “Better Health For All” with the products having strict standard of quality, safety and efficacy through uncompromising research & development approach by complying with the regulatory requirements of WHO cGMP and Quality Management System. By virtue of the highest quality of its products, the company has gained the trust and confidence in the healthcare professionals and patients at home and across the globe.
Responsibilities
- Achieve regional sales targets and ensure sustainable business growth.
- Lead, supervise, and motivate Regional/Area Sales Managers and field force.
- Develop and implement effective sales strategies in alignment with company objectives.
- Monitor field performance through regular visits and provide coaching and guidance.
- Ensure proper execution of promotional and marketing activities in the field.
- Identify business opportunities and expand market coverage.
- Maintain strong relationships with key doctors, hospitals, and stakeholders.
- Coordinate with marketing teams for effective field execution.
- Ensure achievement of sales targets through effective planning and execution, maintain proper credit control, monitor team performance, and develop sustainable sales growth.
Requirements
- Experience: 15-25 years
- Skills: pharmaceutical sales, pharmaceutical marketing, cgmp manufacturing, pharmacy sales, global drug development, pharmaceutical industry, gmp, pharmaceutical, pharmaceuticals
Location: Anywhere in Bangladesh | Job Type: Full-Time | Application deadline: 28 October 2026